ArticleExperimental and therapeutic medicine2023

Roflumilast reduces myocardial ischemia reperfusion injury in vivo and in vitro by activating the AMPK signaling pathway.

Bo Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.